These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 25173926)

  • 1. Novel α-actinin 2 variant associated with familial hypertrophic cardiomyopathy and juvenile atrial arrhythmias: a massively parallel sequencing study.
    Girolami F; Iascone M; Tomberli B; Bardi S; Benelli M; Marseglia G; Pescucci C; Pezzoli L; Sana ME; Basso C; Marziliano N; Merlini PA; Fornaro A; Cecchi F; Torricelli F; Olivotto I
    Circ Cardiovasc Genet; 2014 Dec; 7(6):741-50. PubMed ID: 25173926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy: a genome-wide analysis.
    Chiu C; Bagnall RD; Ingles J; Yeates L; Kennerson M; Donald JA; Jormakka M; Lind JM; Semsarian C
    J Am Coll Cardiol; 2010 Mar; 55(11):1127-35. PubMed ID: 20022194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel nonsense mutation in TNNT2 in a Chinese pedigree with hypertrophic cardiomyopathy: A case report.
    Gao G; Liu G; Chen W; Tong Y; Mao C; Liu J; Zhang X; He MM; Yang P
    Medicine (Baltimore); 2020 Aug; 99(34):e21843. PubMed ID: 32846832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole exome sequencing combined with integrated variant annotation prediction identifies a causative myosin essential light chain variant in hypertrophic cardiomyopathy.
    Nomura A; Tada H; Teramoto R; Konno T; Hodatsu A; Won HH; Kathiresan S; Ino H; Fujino N; Yamagishi M; Hayashi K
    J Cardiol; 2016 Feb; 67(2):133-9. PubMed ID: 26443374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel α-Actin Gene Mutation p.(Ala21Val) Causing Familial Hypertrophic Cardiomyopathy, Myocardial Noncompaction, and Transmural Crypts. Clinical-Pathologic Correlation.
    Frustaci A; De Luca A; Guida V; Biagini T; Mazza T; Gaudio C; Letizia C; Russo MA; Galea N; Chimenti C
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29440008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal recessive transmission of MYBPC3 mutation results in malignant phenotype of hypertrophic cardiomyopathy.
    Wang Y; Wang Z; Yang Q; Zou Y; Zhang H; Yan C; Feng X; Chen Y; Zhang Y; Wang J; Zhou X; Ahmad F; Hui R; Song L
    PLoS One; 2013; 8(6):e67087. PubMed ID: 23840593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYH7 Gene-Related Mutation p.V878L Identified in a Chinese Family with Hypertrophic Cardiomyopathy.
    Du Y; Wang Y; Han X; Feng Z; Ma A
    Int Heart J; 2019 Nov; 60(6):1415-1420. PubMed ID: 31735781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.
    Waldmüller S; Schroeder C; Sturm M; Scheffold T; Imbrich K; Junker S; Frische C; Hofbeck M; Bauer P; Bonin M; Gawaz M; Gramlich M
    Mol Cell Probes; 2015 Oct; 29(5):308-14. PubMed ID: 25979592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next Generation Sequencing and Linkage Analysis for the Molecular Diagnosis of a Novel Overlapping Syndrome Characterized by Hypertrophic Cardiomyopathy and Typical Electrical Instability of Brugada Syndrome.
    Mango R; Luchetti A; Sangiuolo R; Ferradini V; Briglia N; Giardina E; Ferrè F; Helmer Citterich M; Romeo F; Novelli G; Sangiuolo F
    Circ J; 2016; 80(4):938-49. PubMed ID: 26960954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular noncompaction associated with hypertrophic cardiomyopathy: echocardiographic diagnosis and genetic analysis of a new pedigree in China.
    Yuan L; Xie M; Cheng TO; Wang X; Zhu F; Kong X; Ghoorah D
    Int J Cardiol; 2014 Jun; 174(2):249-59. PubMed ID: 24698237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel hypertrophic cardiomyopathy-associated mutation using targeted next-generation sequencing.
    Zhao Y; Feng Y; Ding X; Dong S; Zhang H; Ding J; Xia X
    Int J Mol Med; 2017 Jul; 40(1):121-129. PubMed ID: 28498465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathy.
    Jongbloed RJ; Marcelis CL; Doevendans PA; Schmeitz-Mulkens JM; Van Dockum WG; Geraedts JP; Smeets HJ
    J Am Coll Cardiol; 2003 Mar; 41(6):981-6. PubMed ID: 12651045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Phenotype-Genotype Correlations of Restrictive Cardiomyopathy With Myosin-Binding Protein C (MYBPC3) Gene Mutations Tested by Next-Generation Sequencing.
    Wu W; Lu CX; Wang YN; Liu F; Chen W; Liu YT; Han YC; Cao J; Zhang SY; Zhang X
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26163040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Missense Mutation p.Gly162Glu of the Gene MYL2 Involved in Hypertrophic Cardiomyopathy: A Pedigree Analysis of a Proband.
    Renaudin P; Janin A; Millat G; Chevalier P
    Mol Diagn Ther; 2018 Apr; 22(2):219-223. PubMed ID: 29549657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic cardiomyopathy in the elderly.
    Kubo T; Kitaoka H; Okawa M; Nishinaga M; Doi YL
    Geriatr Gerontol Int; 2010 Jan; 10(1):9-16. PubMed ID: 20102377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of a large duplication mutation in the myosin-binding protein C3 gene in a case of hypertrophic cardiomyopathy.
    Meyer T; Pankuweit S; Richter A; Maisch B; Ruppert V
    Gene; 2013 Sep; 527(1):416-20. PubMed ID: 23816408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel homozygous TPM1 mutation in familial pediatric hypertrophic cardiomyopathy and in silico screening of potential targeting drugs.
    Carlus SJ; Almuzaini IS; Karthikeyan M; Loganathan L; Al-Harbi GS; Carlus FH; Al-Mazroea AH; Morsy MM; Abo-Haded HM; Abdallah AM; Al-Harbi KM
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7732-7744. PubMed ID: 32744700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects.
    Monserrat L; Hermida-Prieto M; Fernandez X; Rodríguez I; Dumont C; Cazón L; Cuesta MG; Gonzalez-Juanatey C; Peteiro J; Alvarez N; Penas-Lado M; Castro-Beiras A
    Eur Heart J; 2007 Aug; 28(16):1953-61. PubMed ID: 17611253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy.
    Cecconi M; Parodi MI; Formisano F; Spirito P; Autore C; Musumeci MB; Favale S; Forleo C; Rapezzi C; Biagini E; Davì S; Canepa E; Pennese L; Castagnetta M; Degiorgio D; Coviello DA
    Int J Mol Med; 2016 Oct; 38(4):1111-24. PubMed ID: 27600940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome sequencing identifies a mutation in the ACTN2 gene in a family with idiopathic ventricular fibrillation, left ventricular noncompaction, and sudden death.
    Bagnall RD; Molloy LK; Kalman JM; Semsarian C
    BMC Med Genet; 2014 Sep; 15():99. PubMed ID: 25224718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.